Laimaphelenchus suberensis sp. nov. associated with Quercus suber in Portugal

Laimaphelenchus suberensis sp. nov. obtained from declining Quercus suber trees of Herdade da Gouveia de Baixo, Alentejo, Portugal, is described and illustrated based on morphological, biometrical and molecular characters. The diagnosis of Laimaphelenchus species has been commonly based on the presence or absence of a vulval flap and on the shape structure of the tail tip. The species described here has been included in the Laimaphelenchus group without vulval flap, and can be distinguished from morphologically similar species by its tail tip shape structure that has a stalk-like terminus and three diffuse tubercles with 4–6 finger-like protrusions. For the molecular analyses, the mitochondrial DNA region from the cytochrome oxidase subunit I (mtCOI), the D2-D3 expansion segments of the large subunit (LSU) and small subunit (SSU) of rRNA gene were amplified and sequenced. Sequences of L. suberensis sp. nov. clustered separately from all Laimaphelenchus spp. with available sequences in Genbank, confirming its identification as a new species. This is the second report of the genus Laimaphelenchus in Portugal, associated with Q. suber: L. heidelbergi and L. suberensis sp. nov.This research was supported by CFE, CIEPQPF and FEDER funds through the ‘Programa Operacional Factores de Competitividade – COMPETE’ and by national funds through FCT–Fundação para a Ciência e a Tecnologia under the projects UID/BIA/04004/2013, PEst-C/EQB/UI0102/2013 and FCOMP-01-0124-008937 (Ref. PTDC/BIA–BEC/102834/2008) and by Instituto do Ambiente, Tecnologia e Vida (IATV). Carla Maleita (SFRH/BPD/85736/2012) and Sofia Costa (SFRH/BPD/ 102438/2014) were financed by MEC National funding and The European Social Fund through POCH (Programa Operacional Capital Humano).info:eu-repo/semantics/publishedVersio

Description of Laimaphelenchus belgradiensis sp nov (Nematoda: Aphelenchoididae) and its phylogenetic and systematic position within Aphelenchoidoidea

Laimaphelenchus belgradiensis sp. nov. is described and illustrated, based on morphological, molecular and morphometric data. The new species belongs to the group of Laimaphelenchus species having a vulval flap. A unique combination of characters distinguishes this parthenogenetic species from others: annulated cephalic region; no labial disc; polygonal median bulb; offset tail terminus with four pedunculate tubercles in a square position that end in 10-12 finger-like protrusions. Morphologically, the new species resembles L. cocuccii and L. deconincki but differs from them by the body length, stylet length, distance from the anterior end to the median bulb, head annulations and tail shape. Bayesian phylogenetic analyses based on 18S and the D2/D3 segment of 28S rRNA genes were performed using sequences of species from 18 genera within the Aphelenchoidoidea. The resulting phylogenetic trees generated three distinct clades representing three families: Aphelenchoididae, Ektaphelenchidae and Parasitaphelenchidae. In the 18S tree L. belgradiensis sp. nov. forms a clade with L. penardi and in the 28S tree the new species is close to L. persicus and L. preissii

Stabilization of the Max Homodimer with a Small Molecule Attenuates Myc-Driven Transcription

The transcription factor Max is a basic-helix-loop-helix leucine zipper (bHLHLZ) protein that forms homodimers or interacts with other bHLHLZ proteins, including Myc and Mxd proteins. Among this dynamic network of interactions, the Myc/Max heterodimer has crucial roles in regulating normal cellular processes, but its transcriptional activity is deregulated in a majority of human cancers. Despite this significance, the arsenal of high-quality chemical probes to interrogate these proteins remains limited. We used small molecule microarrays to identify compounds that bind Max in a mechanistically unbiased manner. We discovered the asymmetric polycyclic lactam, KI-MS2-008, which stabilizes the Max homodimer while reducing Myc protein and Myc-regulated transcript levels. KI-MS2-008 also decreases viable cancer cell growth in a Myc-dependent manner and suppresses tumor growth in vivo. This approach demonstrates the feasibility of modulating Max with small molecules and supports altering Max dimerization as an alternative approach to targeting Myc.National Cancer Institute (Grant R01-CA160860)National Cancer Institute (Grant P30-CA14051)National Cancer Institute (Grant U01-CA176152)National Cancer Institute (Grant CA170378PQ2)National Institutes of Health (Grant CA170378PQ2